Interesting parallels Gas, with this ISIS study.
The main target was to reduce Triglycerides, also produced in the liver, to normalized levels.
In healthy patients with normalised levels ISIS' drug reduced these levels by 44% (in a 4 week trial).
In the latest Ph 2 with patients having above normal levels, they managed to reduce it by 71% (in a 13 week trial).
Another aspect to ponder while we wait.
- Forums
- ASX - By Stock
- loyalty options date and atl1103 results
Interesting parallels Gas, with this ISIS study.The main target...
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.001(1.27%) |
Mkt cap ! $82.94M |
Open | High | Low | Value | Volume |
8.0¢ | 8.3¢ | 7.9¢ | $461.5K | 5.711M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 844186 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 292500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 844186 | 0.080 |
8 | 506274 | 0.079 |
5 | 575000 | 0.078 |
8 | 1027327 | 0.077 |
4 | 346421 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 292500 | 1 |
0.083 | 30000 | 1 |
0.084 | 93750 | 1 |
0.085 | 187500 | 2 |
0.086 | 250000 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online